Clinical Trials Arena on MSN
Digital twins for clinical trials: early days, rapid momentum
While digital twins have progressed, there are still a range of ethical, regulatory and data-driven hurdles that must be ...
Dimension Bio, a biotechnology company pioneering regenerative therapeutics, today announced the formation of its inaugural Clinical Advisory Board (CAB) and Scientific Advisory Board (SAB). The ...
If the drug works in people, it could prevent kidney injury in high-risk populations, or potentially even treat other ...
The landscape of coronary and pulmonary vascular medicine is undergoing a paradigm shift, fueled by breakthroughs in molecular biology, imaging, and ...
The field of physiological monitoring is undergoing a transformative shift, moving beyond traditional, often invasive, measurements towards integrated, dynamic, and non-invasive assessments. This ...
Shares of Replimune Group, Inc. (NASDAQ:REPL) are rising Monday after the clinical stage biotechnology company shared an important regulatory update. What To Know: Replimune said the U.S. Food and ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results
Feedback